Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
DOCS
#1172
Doximity, Inc.
24.4
9
-1.92%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-1.92%
Variazione Mensile
-37.80%
Variazione di 6 mesi
-63.99%
Variazione Annuale
-64.17%
Chiusura Precedente
24.9
7
Open
24.3
5
Bid
Ask
Low
24.3
2
High
24.5
5
Volume
1 944
Mercati
Mercato Azionario Statunitense
Salute
DOCS
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Cash from operating activities
65.19 M
98.49 M
62.1 M
93.94 M
60.89 M
315.42 M
Cash from investing activities
-49.27 M
24.47 M
2.68 M
26.35 M
-19.84 M
33.67 M
Cash from financing activities
25.24 M
29.67 M
137.13 M
30.25 M
203.53 M
400.57 M
Free cash flow
63.42 M
96.98 M
60.13 M
91.58 M
58.58 M
307.27 M
Doximity Inc Class A
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration. The company is based in San Francisco.
Notizie
Il titolo Doximity tocca il minimo a 52 settimane a 23,65$
Doximity stock hits 52-week low at $23.65 amid challenging year
Piper Sandler alza il target sul titolo Doximity grazie agli strumenti AI
Piper Sandler raises Doximity stock price target on AI tools
Teladoc Q4 Earnings: Can Integrated Care Strength Save Profits?
Harbor Active Small Cap ETF Q4 2025 Scorecard: Buys, Sells, And Standouts
Walmart Earnings, FOMC Meeting Minutes In Focus Next Week
PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up
Should You Buy, Hold or Sell Tempus AI Stock Pre-Q4 Earnings Release?
AVTR Stock Plunges Despite Q4 Earnings Beat Estimates, Margins Decline
QuidelOrtho Q4 Earnings and Revenues Beat Estimates, Margins Down
Doximity Stock: Growth Outlook Is Murky (NYSE:DOCS)